LivaNova plc (LIVN) Tops Q3 EPS by 3c; Appoints New CEO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Qualcomm (QCOM) Reports In-Line Q4 EPS, Beats on Revenue; Offers Q1 Guidance
- Intel shares fall as competitor reports record results
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- SanDisk shares fall on election and chip sector pressure
- After-Hours Movers: QCOM, COHR, APP, HUBS, SNAP, FSLY, FIG, ZG, BROS, CDE
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
LivaNova Reports Third Quarter 2016 Results
November 2, 2016 7:46 AM EDTLONDON, Nov. 02, 2016 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ: LIVN)Â (LSE: LIVN) (LivaNova or the Company), a market-leading medical technology and innovation company, today reported results for the third quarter ended September 30, 2016.Â
For the third quarter of 2016, worldwide sales were $295 million, an increase of 3.2 percent on a reported basis and an increase of 2.4 percent on a constant-currency basis1, as compared to the previous year. On a U.S. Generally Accepted Accounting Principles (GAAP) basis, third quarter 2016 loss per share was $0.03. ... More
LivaNova PLC Announces CEO Transition: Damien McDonald to Succeed André-Michel Ballester
November 2, 2016 6:30 AM EDTLONDON, Nov. 02, 2016 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ: LIVN) (LSE: LIVN) (LivaNova or the Company), a market-leading medical technology and innovation company, today named Damien McDonald as the companys new Chief Executive Officer (CEO) and board member, effective January 1, 2017. McDonald currently serves as LivaNovas Chief Operating Officer, and will succeed André-Michel Ballester, who will resign effective December 31, 2016.
Ballester served as CEO of Sorin S.p.A. (Sorin) from 2007 to 2015, prior to the October 2015 merger of Sorin and Cyberonics, Inc. (Cyberonics) to create... More



